Talk:Rituximab
From Wikipedia, the free encyclopedia
[edit] Use of rituximab
While it is true that the FDA-approved use of rituximab is for relapsed or refractory lymphoma, its off label use in combination with CHOP is standard clinical practice in the U.S. for treating e.g. diffuse large B cell lymphoma upfront. Andrew73 20:28, 22 October 2005 (UTC)
[edit] SLE
I could not find one nice representative study to illustrate the SLE thing. PMID 15550531 is a hodgepodge of diseases and not really useful. JFW | T@lk 22:30, 3 January 2006 (UTC)
[edit] Epitope on CD20
PMID 16705086 - they've been looking for the bit of CD20 that rituximab binds to. JFW | T@lk 21:12, 6 September 2006 (UTC)
